Taligen Therapeutics, a biotechnology company developing therapies that regulate the complement system to treat inflammatory and immune diseases, today announced that it has closed on a $10 million tranche of a Series B financing, based on substantial progress with the company’s product pipeline including advancing the lead product candidate, TT30, toward clinical development.
From genetic testing to earlier cancer diagnosis, to rapid result strep tests and diagnostic tools that can be used outside of a traditional hospital environment, biotechnology researchers are making great strides in the field of …
The potential health benefits of beer and wine; Biotechnology and the future of food Series: UC Davis Frontiers.
to MBA, navigating the pharmaceutical and biotech industries, implementing change within … unlock their talent by providing a practical, student-centered education that prepares them for careers in some of the fastest-growing …
Volume 10 on Special Processes completes the Second Edition of the Biotechnology series providing an overview on innovative and special fields of biotechnology . In the other volumes of the series many larger areas of biotechnology are …
ViaGuru Health and Fitness Gurus give free tips, how to ideas, product suppliers reviews and updates on Disease and Illness – Autism is a developmental disability that affects both children and adults.
The potential health benefits of beer and wine; Biotechnology and the future of food Series: UC Davis Frontiers.
Biolexis is a premiere online resource for life sciences professionals, investors and entrepreneurs. The site offers personalized information biotechnology news and other biotechnology resources. Information is further organized by industry sector, therapeutic areas, technology focus, service orientation, and location. With Biolexis, you can: access over 5,000 biotechnology news strories and biotechnology articles. Search biotech company information, biotech news, biotech articles and biotech related press releases.